The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Pulmonary Drug Toxicity: Radiologic and Pathologic Manifestations
Abstract
Pulmonary drug toxicity is increasingly being diagnosed as a cause of acute and chronic lung disease. Numerous agents including cytotoxic and noncytotoxic drugs have the potential to cause pulmonary toxicity. The clinical and radiologic manifestations of these drugs generally reflect the underlying histopathologic processes and include diffuse alveolar damage (DAD), nonspecific interstitial pneumonia (NSIP), bronchiolitis obliterans organizing pneumonia (BOOP), eosinophilic pneumonia, obliterative bronchiolitis, pulmonary hemorrhage, edema, hypertension, or veno-occlusive disease. DAD is a common manifestation of pulmonary drug toxicity and is frequently caused by cytotoxic drugs, especially cyclophosphamide, bleomycin, and carmustine. It manifests radiographically as bilateral hetero- or homogeneous opacities usually in the mid and lower lungs and on high-resolution computed tomographic (CT) scans as scattered or diffuse areas of ground-glass opacity. NSIP occurs most commonly as a manifestation of carmustine toxicity or of toxicity from noncytotoxic drugs such as amidarone. At radiography, it appears as diffuse areas of heterogeneous opacity, whereas early CT scans show diffuse ground-glass opacity and late CT scans show fibrosis in a basal distribution. BOOP, which is commonly caused by bleomycin and cyclophosphamide (as well as gold salts and methotrexate), appears on radiographs as hetero- and homogeneous peripheral opacities in both upper and lower lobes and on CT scans as poorly defined nodular consolidation, centrilobular nodules, and bronchial dilatation. Knowledge of these manifestations and of the drugs most frequently involved can facilitate diagnosis and institution of appropriate treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bronchiolitis Obliterans Organizing Pneumonia
Epler, G. R., Colby, T. V., McLoud, T. C., Carrington, C. B., & Gaensler, E. A. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120304 · Cited by 1,046
Druginduced pulmonary disease. Part 1 : Cytotoxic drugs
Cooper, C. (1986) · Medical Entomology and Zoology · Cited by 543
Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
Malik, S. W., Myers, J. L., DeRemee, R. A., & Specks, U. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.6.8970380 · Cited by 274
The Taxoids: Comparative Clinical Pharmacology and Therapeutic Potential
Eisenhauer, E. A., & Vermorken, J. B. (1998) · Drugs · doi:10.2165/00003495-199855010-00002 · Cited by 248
The pulmonary toxicity of antineoplastic agents.
Ginsberg, S. J., & Comis, R. L. (1982) · PubMed · Cited by 235
Drug-induced Pulmonary Disease
Rosenow, E. C., Myers, J. L., Swensen, S. J., & Pisani, R. J. (1992) · Chest · doi:10.1378/chest.102.1.239 · Cited by 175
Drug-Induced Lung Disease: High-Resolution CT Findings
Ellis, S. J., Cleverley, J., & Müller, N. L. (2000) · American Journal of Roentgenology · doi:10.2214/ajr.175.4.1751019 · Cited by 153
Drug-induced pulmonary disease
Rosenow, E. C. (1994) · Disease-a-Month · doi:10.1016/0011-5029(94)90025-6 · Cited by 122
Pulmonary Infiltrates Following Administration of Paclitaxel
Ramanathan, R. K., Reddy, V. V., Holbert, J. M., & Belani, C. P. (1996) · CHEST Journal · doi:10.1378/chest.110.1.289 · Cited by 68
Cited by
Idiopathic Nonspecific Interstitial Pneumonia: Report of an American Thoracic Society Project
Travis, W. D., Hunninghake, G., King, T. E., Lynch, D. A., Colby, T. V., Galvin, J. R., Brown, K. K., Chung, M. P., Cordier, J.-F., du Bois, R. M., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200611-1685oc · Cited by 599
Kudoh, S., Kato, H., Nishiwaki, Y., Fukuoka, M., Nakata, K., Ichinose, Y., Tsuboi, M., Yokota, S., Nakagawa, K., Suga, M., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200710-1501oc · Cited by 477
COVID-19 pneumonia: A review of typical CT findings and differential diagnosis
Hani, C., Trieu, N. H., Saab, I., Dangeard, S., Bennani, S., Chassagnon, G., & Revel, M.-P. (2020) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2020.03.014 · Cited by 435
Interstitial Lung Disease Induced by Drugs and Radiation
Camus, P., Fanton, A., Bonniaud, P., Camus, C., & Foucher, P. (2004) · Respiration · doi:10.1159/000079633 · Cited by 393
Kinder, B. W., Collard, H. R., Koth, L., Daikh, D. I., Wolters, P. J., Elicker, B., Jones, K. D., & King, T. E. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-220oc · Cited by 381
Metadata
- Authors
- Rossi, S. E., Erasmus, J. J., McAdams, H. P., Sporn, T. A., & Goodman, P. C.
- Venue
- RadioGraphics
- Published
- 2000-09
- Volume
- 20
- Issue
- 5
- Pages
- 1245-1259
- ISSN
- 0271-5333 (ISSN-L)
- 1527-1323
- OpenAlex
- W1965717335
- Cited by
- 449
- References
- 9
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pulmonary Drug Toxicity: Radiologic and Pathologic Manifestations. https://app.cochat.ai/papers/10.1148/radiographics.20.5.g00se081245
- The paper
- Rossi, S. E., Erasmus, J. J., McAdams, H. P., Sporn, T. A., & Goodman, P. C. (2000). Pulmonary Drug Toxicity: Radiologic and Pathologic Manifestations. RadioGraphics. https://doi.org/10.1148/radiographics.20.5.g00se081245
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.